Edwards Lifesciences (EW)
(Delayed Data from NYSE)
$79.33 USD
+0.02 (0.03%)
Updated Aug 1, 2025 03:59 PM ET
After-Market: $79.32 -0.01 (-0.01%) 7:58 PM ET
3-Hold of 5 3
D Value F Growth A Momentum D VGM
Fundamental Charts
About Dividend Yield (TTM)
Edwards Lifesciences Corporation's dividend yield currently sits at 0%, which is in-line with the Medical - Instruments industry's yield of 0.00%.
The company's trailing twelve month (TTM) Dividend Yield calculates the indicated annual dividend divided by the stock price. This value is always expressed as a percentage. This is the return on investment that is specifically attributed to the expected dividends that are paid out over a year. Note: investors should not base their investments on the size of the dividend yield alone. Seek attractive dividend yields, but only on top rated stocks with a solid payment history.
EW 79.33 +0.02(0.03%)
Will EW be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for EW based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for EW
ENSG's Q2 Earnings Beat on Higher Occupancy Rates, Stock Up 9%
HCA Beats Q2 Earnings on Higher Admissions, Ups '25 EPS View
EW: What are Zacks experts saying now?
Zacks Private Portfolio Services
EW Stock Climbs on Q2 Earnings & Revenue Beat, Margins Down
Compared to Estimates, Edwards Lifesciences (EW) Q2 Earnings: A Look at Key Metrics
Robust TMTT Growth to Drive Edwards Lifesciences' Q2 Earnings
Other News for EW
Citadel Advisors LLC Increases Stake in NioCorp Developments Ltd
Agree To Purchase Edwards Lifesciences At $65, Earn 5.2% Using Options
Edwards Lifesciences Corp (EW)'s Winning Formula: Financial Metrics and Competitive Strengths
Sarepta upgraded, Tapestry downgraded: Wall Street's top analyst calls
Daiwa gets more bullish on Edwards Lifesciences, upgrades shares